Literature DB >> 23335101

Protein tyrosine phosphatase expression profile of rheumatoid arthritis fibroblast-like synoviocytes: a novel role of SH2 domain-containing phosphatase 2 as a modulator of invasion and survival.

Stephanie M Stanford1, Michael F Maestre, Amanda M Campbell, Beatrix Bartok, William B Kiosses, David L Boyle, Heather A Arnett, Tomas Mustelin, Gary S Firestein, Nunzio Bottini.   

Abstract

OBJECTIVE: The fibroblast-like synoviocytes (FLS) in the synovial intimal lining of the joint are key mediators of inflammation and joint destruction in rheumatoid arthritis (RA). In RA, these cells aggressively invade the extracellular matrix, producing cartilage-degrading proteases and inflammatory cytokines. The behavior of FLS is controlled by multiple interconnected signal transduction pathways involving reversible phosphorylation of proteins on tyrosine residues. However, little is known about the role of the protein tyrosine phosphatases (PTPs) in FLS function. This study was undertaken to explore the expression of all of the PTP genes (the PTPome) in FLS.
METHODS: A comparative screening of the expression of the PTPome in FLS from patients with RA and patients with osteoarthritis (OA) was conducted. The functional effect on RA FLS of SH2 domain-containing phosphatase 2 (SHP-2), a PTP that was up-regulated in RA, was then analyzed by knockdown using cell-permeable antisense oligonucleotides.
RESULTS: PTPN11 was overexpressed in RA FLS compared to OA FLS. Knockdown of PTPN11, which encodes SHP-2, reduced the invasion, migration, adhesion, spreading, and survival of RA FLS. Additionally, signaling in response to growth factors and inflammatory cytokines was impaired by SHP-2 knockdown. RA FLS that were deficient in SHP-2 exhibited decreased activation of focal adhesion kinase and mitogen-activated protein kinases.
CONCLUSION: These findings indicate that SHP-2 has a novel role in mediating human FLS function and suggest that it promotes the invasiveness and survival of RA FLS. Further investigation may reveal SHP-2 to be a candidate therapeutic target for RA.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335101      PMCID: PMC3636201          DOI: 10.1002/art.37872

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  47 in total

1.  Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.

Authors:  T M Saxton; M Henkemeyer; S Gasca; R Shen; D J Rossi; F Shalaby; G S Feng; T Pawson
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

2.  PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase.

Authors:  Rebecca J Chan; Gen-Sheng Feng
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

3.  Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues.

Authors:  Paul A Morcos; Yongfu Li; Shan Jiang
Journal:  Biotechniques       Date:  2008-12       Impact factor: 1.993

Review 4.  The role of resident synovial cells in destructive arthritis.

Authors:  Caroline Ospelt; Steffen Gay
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-04       Impact factor: 4.098

5.  The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts.

Authors:  Teresina Laragione; Max Brenner; Adriana Mello; Marc Symons; Pércio S Gulko
Journal:  Arthritis Rheum       Date:  2008-08

Review 6.  The tyrosine phosphatase Shp2 (PTPN11) in cancer.

Authors:  Gordon Chan; Demetrios Kalaitzidis; Benjamin G Neel
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

7.  Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cells.

Authors:  X-D Zhou; Y M Agazie
Journal:  Cell Death Differ       Date:  2008-04-18       Impact factor: 15.828

Review 8.  The role and therapeutic implications of fibroblast-like synoviocytes in inflammation and cartilage erosion in rheumatoid arthritis.

Authors:  Erika H Noss; Michael B Brenner
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

Review 9.  Targeting PTPs with small molecule inhibitors in cancer treatment.

Authors:  Zhong-Xing Jiang; Zhong-Yin Zhang
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

10.  Noonan syndrome/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis.

Authors:  Siying Wang; Wen-Mei Yu; Wanming Zhang; Keith R McCrae; Benjamin G Neel; Cheng-Kui Qu
Journal:  J Biol Chem       Date:  2008-11-13       Impact factor: 5.157

View more
  22 in total

1.  Decreased UBASH3A mRNA Expression Levels in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus.

Authors:  Jie Liu; Jing Ni; Lian-Ju Li; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

2.  PTPN14 phosphatase and YAP promote TGFβ signalling in rheumatoid synoviocytes.

Authors:  Angel Bottini; Dennis J Wu; Rizi Ai; Michelle Le Roux; Beatrix Bartok; Michele Bombardieri; Karen M Doody; Vida Zhang; Cristiano Sacchetti; Martina Zoccheddu; Ana Lonic; Xiaochun Li; David L Boyle; Deepa Hammaker; Tzu-Ching Meng; Lin Liu; Maripat Corr; Stephanie M Stanford; Myles Lewis; Wei Wang; Gary S Firestein; Yeesim Khew-Goodall; Costantino Pitzalis; Nunzio Bottini
Journal:  Ann Rheum Dis       Date:  2019-02-26       Impact factor: 19.103

3.  Abnormal PTPN11 enhancer methylation promotes rheumatoid arthritis fibroblast-like synoviocyte aggressiveness and joint inflammation.

Authors:  Keisuke Maeshima; Stephanie M Stanford; Deepa Hammaker; Cristiano Sacchetti; Li-Fan Zeng; Rizi Ai; Vida Zhang; David L Boyle; German R Aleman Muench; Gen-Sheng Feng; John W Whitaker; Zhong-Yin Zhang; Wei Wang; Nunzio Bottini; Gary S Firestein
Journal:  JCI Insight       Date:  2016-05-19

Review 4.  Epigenetic alterations in rheumatoid arthritis fibroblast-like synoviocytes.

Authors:  Karen M Doody; Nunzio Bottini; Gary S Firestein
Journal:  Epigenomics       Date:  2017-03-21       Impact factor: 4.778

5.  TGFβ responsive tyrosine phosphatase promotes rheumatoid synovial fibroblast invasiveness.

Authors:  Stephanie M Stanford; German R Aleman Muench; Beatrix Bartok; Cristiano Sacchetti; William B Kiosses; Jay Sharma; Michael F Maestre; Massimo Bottini; Tomas Mustelin; David L Boyle; Gary S Firestein; Nunzio Bottini
Journal:  Ann Rheum Dis       Date:  2014-11-06       Impact factor: 19.103

Review 6.  Targeting Tyrosine Phosphatases: Time to End the Stigma.

Authors:  Stephanie M Stanford; Nunzio Bottini
Journal:  Trends Pharmacol Sci       Date:  2017-04-12       Impact factor: 14.819

7.  Receptor Protein Tyrosine Phosphatase α-Mediated Enhancement of Rheumatoid Synovial Fibroblast Signaling and Promotion of Arthritis in Mice.

Authors:  Stephanie M Stanford; Mattias N D Svensson; Cristiano Sacchetti; Caila A Pilo; Dennis J Wu; William B Kiosses; Annelie Hellvard; Brith Bergum; German R Aleman Muench; Christian Elly; Yun-Cai Liu; Jeroen den Hertog; Ari Elson; Jan Sap; Piotr Mydel; David L Boyle; Maripat Corr; Gary S Firestein; Nunzio Bottini
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995

Review 8.  Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes.

Authors:  Gyrid Nygaard; Gary S Firestein
Journal:  Nat Rev Rheumatol       Date:  2020-05-11       Impact factor: 20.543

9.  Targeting phosphatase-dependent proteoglycan switch for rheumatoid arthritis therapy.

Authors:  Karen M Doody; Stephanie M Stanford; Cristiano Sacchetti; Mattias N D Svensson; Charlotte H Coles; Nikolaos Mitakidis; William B Kiosses; Beatrix Bartok; Camille Fos; Esther Cory; Robert L Sah; Ru Liu-Bryan; David L Boyle; Heather A Arnett; Tomas Mustelin; Maripat Corr; Jeffrey D Esko; Michel L Tremblay; Gary S Firestein; A Radu Aricescu; Nunzio Bottini
Journal:  Sci Transl Med       Date:  2015-05-20       Impact factor: 17.956

10.  The tyrosine phosphatase SHP-2 dephosphorylated by ALV-J via its Env efficiently promotes ALV-J replication.

Authors:  Tuofan Li; Jing Xie; Xiaohui Yao; Jun Zhang; Chunping Li; Dan Ren; Luyuan Li; Quan Xie; Hongxia Shao; Aijian Qin; Jianqiang Ye
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.